Mostrar el registro sencillo del ítem
dc.contributor.author
Sookoian, Silvia Cristina
dc.contributor.author
Pirola, Carlos José
dc.date.available
2018-03-14T18:56:52Z
dc.date.issued
2016-06
dc.identifier.citation
Sookoian, Silvia Cristina; Pirola, Carlos José; How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals?; W B Saunders Co-Elsevier Inc; Gastroenterology; 150; 8; 6-2016; 1698-1703
dc.identifier.issn
0016-5085
dc.identifier.uri
http://hdl.handle.net/11336/38760
dc.description.abstract
The prevalence of nonalcoholic fatty liver disease (NAFLD) has reached global epidemic proportions,1 paralleling that of the increasing trends in the prevalence of obesity and type 2 diabetes (T2D). In fact, obesity is one of the most frequently associated comorbidities of NAFLD,2 and, furthermore, NAFLD and obesity integrate the myriad risk factors for cardiovascular disease (CVD) clustered in the metabolic syndrome (MetS). By definition, NAFLD is characterized by abnormal liver fat accumulation in the absence of significant alcohol consumption and other causes of secondary hepatic steatosis. Once diagnosed, the treatment of NAFLD is complex and often requires pharmacologic intervention to control associated risk factors and/or lifestyle modifications. Conflicting results on whether social or moderate alcohol consumption (MAC) is detrimental or beneficial leave physicians uncertain as to whether or not to apply tight restrictions or allow low levels of social alcohol use for potential health benefit.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
W B Saunders Co-Elsevier Inc
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.subject
Alcohol Consumption
dc.subject
Fibrosis
dc.subject
Mendelian Randomization
dc.subject
Nafld
dc.subject.classification
Medicina Critica y de Emergencia
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals?
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2018-03-14T17:13:09Z
dc.journal.volume
150
dc.journal.number
8
dc.journal.pagination
1698-1703
dc.journal.pais
Estados Unidos
dc.description.fil
Fil: Sookoian, Silvia Cristina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Pirola, Carlos José. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.journal.title
Gastroenterology
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1053/j.gastro.2016.01.002
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0016508516000056
Archivos asociados